Pharma Capital
Showing 40 of 40
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £81.17m £0.38 0.00% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £16.09m £0.21 -5.62% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £10.01m £1.13 0.00% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £160.41m £0.27 0.00% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £251.85m £0.53 3.90% ico_glass.png
amryt-pharma.jpg Amryt Pharmaceuticals AIM £55.21m £0.27 -1.85% ico_glass.png
angle-logo.png ANGLE plc AIM £38.16m £0.51 0.99% ico_glass.png
avacta.png Avacta Group Plc AIM £66.00m £0.97 0.00% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £41.07m £0.90 0.00% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £1,011.73m £8.79 1.56% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £16.21m £0.05 2.56% ico_glass.png
concepta.png Concepta AIM £17.27m £0.16 0.80% ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £12.24m £0.04 13.79% ico_glass.png
E--therapeutics-logo.png e-Therapeutics plc AIM £20.47m £0.08 0.00% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £83.43m £2.06 0.00% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £216.04m £7.78 0.65% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £67.55m £0.56 0.90% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £7.94m £0.43 0.00% ico_glass.png
Horizon-logo.2.png Horizon Discovery Group PLC AIM £207.84m £2.16 -0.46% ico_glass.png
imm.gif ImmuPharma PLC AIM £72.06m £0.54 0.69% ico_glass.png
ixico-logo.png IXICO Plc AIM £8.68m £0.32 0.00% ico_glass.png
MaxCyte.gif MaxCyte AIM £138.47m £2.73 -1.80% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £52.84m £1.09 -0.46% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £63.66m £0.33 3.17% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £25.79m £0.51 0.00% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £58.91m £0.75 -0.66% ico_glass.png
redx-logo.png Redx Pharma Plc AIM £40.95m £0.32 -1.52% ico_glass.png
reneuron_logo.png ReNeuron Group Plc AIM £61.71m £0.02 0.00% ico_glass.png
rex_bionics_logo.png Rex Bionics PLC AIM £0.45m £0.02 -30.00% ico_glass.png
sar.jpg Sareum Holdings Plc AIM £23.15m £0.01 0.00% ico_glass.png
scancell.gif Scancell Holdings Plc AIM £33.94m £0.11 0.00% ico_glass.png
silence-logo-2.jpg Silence Therapeutics plc AIM £67.19m £0.96 0.39% ico_glass.png
sphere_medical_sponsor_logo.gif Sphere Medical Holding PLC AIM £10.45m £0.07 0.00% ico_glass.png
summit_corp_logo.png Summit Therapeutics PLC AIM £111.31m £1.80 1.41% ico_glass.png
synairgen-latest.jpg Synairgen plc AIM £9.36m £0.10 0.00% ico_glass.png
tissue_regenix_sponsor_logo.png Tissue Regenix Group PLC AIM £114.21m £0.15 0.00% ico_glass.png
Valirx-logo.png ValiRx Plc AIM £3.20m £0.02 -1.03% ico_glass.png
Venn-life-logo.png Venn Life Sciences Holdings plc AIM £8.97m £0.15 0.00% ico_glass.png
WideCellsGroup-2.jpg WideCells Group LSE £6.91m £0.12 0.00% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.